上集講述了PD1/PDL1在醫治癌細胞免疫治療方面的重要性，接下來我們將會繼續深入探討問題。1394Please respect copyright.ＰＥＮＡＮＡQNx9J9CaDZ
1394Please respect copyright.ＰＥＮＡＮＡN0DBdQc2Sf
上集：https://www.penana.com/article/4711251394Please respect copyright.ＰＥＮＡＮＡS7KRONnKOd
1394Please respect copyright.ＰＥＮＡＮＡ45SNalml7W
1394Please respect copyright.ＰＥＮＡＮＡQs2ibh6fg9
1394Please respect copyright.ＰＥＮＡＮＡvapvPYhosw
（圖1）雖然阻擋PD1/PDL1可以增強T cell辨認癌細胞的能力，但另一個重要的問題是，如何確保有足夠的T cell殺滅癌細胞呢?1394Please respect copyright.ＰＥＮＡＮＡCHAAs0GCD0
1394Please respect copyright.ＰＥＮＡＮＡRXQBHgA1L8
就算成功糾正免疫系統細胞懂得把癌細胞辨認為外來之物，但免疫系統細胞數量不足的話，依然是不會達到重大效果的。1394Please respect copyright.ＰＥＮＡＮＡxu5FQwKRPv
1394Please respect copyright.ＰＥＮＡＮＡrtnp6fXoiH
換句話說，我們需要一道能夠提升針對癌細胞的T cell數量手段。1394Please respect copyright.ＰＥＮＡＮＡvP9ajHIJDl
1394Please respect copyright.ＰＥＮＡＮＡEEnxTjlU2E
1394Please respect copyright.ＰＥＮＡＮＡO1H5IkNW2q
1394Please respect copyright.ＰＥＮＡＮＡHg8kipvKOg
（圖2）T cell的產生數量，接近可以說是由Antigen Presenting Cells(APC)來決定;1394Please respect copyright.ＰＥＮＡＮＡN6fWEZLx7H
APC可以睇成為一堆負責把癌細胞獨特Neoantigen帶來T cell面前的細胞。1394Please respect copyright.ＰＥＮＡＮＡxZhywnyZDG
1394Please respect copyright.ＰＥＮＡＮＡRyAVBi4PMz
忘記甚麼是Neoantigen的話，可重溫上一集。1394Please respect copyright.ＰＥＮＡＮＡXyMELQH8mw
1394Please respect copyright.ＰＥＮＡＮＡrIcdD653QK
當APC展示癌細胞的Neoantigen予T cell的receptor後，另一個必需的動作就是T cell表面的CD28與APC表面的B7合併。1394Please respect copyright.ＰＥＮＡＮＡ8GCkRG4zOD
1394Please respect copyright.ＰＥＮＡＮＡj4YRd3SpSs
只要兩者條件達成的話，負責對付對應癌細胞的T cell數量及效力便會大增。1394Please respect copyright.ＰＥＮＡＮＡeWMFPqPWu3
1394Please respect copyright.ＰＥＮＡＮＡTQMw5xXhR0
1394Please respect copyright.ＰＥＮＡＮＡVPYXO0WeKq
1394Please respect copyright.ＰＥＮＡＮＡIKKmifNvhb
（圖3）然而，當T cell數量產生至一定程度的時候，T cell便會產生出CTLA4。CTLA4會搶奪CD28的位置，與B7合併。1394Please respect copyright.ＰＥＮＡＮＡcjJF6Vo8zP
1394Please respect copyright.ＰＥＮＡＮＡBxtRdkxS8M
而當CTLA4與B7合併後，T cell所產生的數量及威力就會大減。1394Please respect copyright.ＰＥＮＡＮＡS9RcGKpmhp
1394Please respect copyright.ＰＥＮＡＮＡqWzYFKM0d3
這個CTLA4產生的機制是與生俱來的，目的就是為了避免產生過量的T cell，以免身體會產生不良反應。1394Please respect copyright.ＰＥＮＡＮＡV0gaucew9A
1394Please respect copyright.ＰＥＮＡＮＡqy0SyrcV01
1394Please respect copyright.ＰＥＮＡＮＡNDxRb9OUdR
（圖4）只不過的是，現時癌細胞大敵當前，燃眉之急就是要調動大量的T cell前往討伐癌細胞。1394Please respect copyright.ＰＥＮＡＮＡz8WEbxGZE2
1394Please respect copyright.ＰＥＮＡＮＡFs3dgr7zlp
為此，我們重施應對PD1/PDL1故技，利用抗體阻擋CTLA4，確保CD28及B7持續合併，不斷產生效力高強的T cell。1394Please respect copyright.ＰＥＮＡＮＡNrYOqbW50b
1394Please respect copyright.ＰＥＮＡＮＡzcwRDknSt1
1394Please respect copyright.ＰＥＮＡＮＡDw8pRujAjS
（圖5）簡略的總結來說，為了確保有足夠的T cell消滅癌細胞，我們不惜採用阻擋CTLA4的抗體，號令身體持續產生效力高強的T cell。1394Please respect copyright.ＰＥＮＡＮＡVhqo6pCqU4
而另一邊廂，我們亦同時利用阻擋PD1/PDL1的抗體，確保T cell能夠順利把癌細胞辨認成為外來物，將其制裁。1394Please respect copyright.ＰＥＮＡＮＡeG8XWmdtSG
1394Please respect copyright.ＰＥＮＡＮＡymMADeA6eS
這CTLA4抗體及PD1/PDL1抗體的雙管齊下療法，將能大大提升免疫治療的效率。1394Please respect copyright.ＰＥＮＡＮＡ7Z9LhGNdXG
1394Please respect copyright.ＰＥＮＡＮＡiLhxSueJ6F
但是，並不是所有病人也能依靠這方法而得益，原因是T cell沒法能夠順利抵達癌細胞的位置以及滲入癌細胞的內部作有效的消滅。1394Please respect copyright.ＰＥＮＡＮＡjESIM8T5ei
1394Please respect copyright.ＰＥＮＡＮＡ04Z8dXmm2T
這一方面，我們將會在下一篇免疫治療的最終章再作探討。1394Please respect copyright.ＰＥＮＡＮＡ4oCB5CnbJJ
1394Please respect copyright.ＰＥＮＡＮＡHK6zrTfkjU
1394Please respect copyright.ＰＥＮＡＮＡ5jD8VsUabE
如果想我快啲出文的話，請入去Penana網站科普專欄–薯不揀單俾一個like以及Bookmark，這對我非常之重要。1394Please respect copyright.ＰＥＮＡＮＡelAC9MlDTw
1394Please respect copyright.ＰＥＮＡＮＡ9sH4wfeLOF
Link: https://www.penana.com/story/66244/%E7%A7%91%E6%99%AE%E5%B0%88%E6%AC%84-%E8%96%AF%E4%B8%8D%E6%8F%80%E5%96%AE/toc1394Please respect copyright.ＰＥＮＡＮＡ8UluhihCZy
1394Please respect copyright.ＰＥＮＡＮＡpHRzco3NKl
同時亦可以在Penana網站裡按「買一嚿/半嚿薯仔」，以課金的方式推動我繼續搜羅資料寫文，多謝。1394Please respect copyright.ＰＥＮＡＮＡISyvT3Gl0V
1394Please respect copyright.ＰＥＮＡＮＡtcFIwFoZn8
Link:1394Please respect copyright.ＰＥＮＡＮＡAn6lTsdCwL
https://www.penana.com/user/27349/%E8%96%AF%E4%BB%94%E8%81%9E%E8%8C%B1%E8%8E%89/portfolio1394Please respect copyright.ＰＥＮＡＮＡv2Q4JIZA1v
1394Please respect copyright.ＰＥＮＡＮＡ5fqoBNQX7s
1394Please respect copyright.ＰＥＮＡＮＡTYTNFTJk2m
有興趣接收科普資訊的話，歡迎follow IG: potatopigtongue。1394Please respect copyright.ＰＥＮＡＮＡsL524KElPX
Penana
search
登入arrow_drop_down
註冊arrow_drop_down
